| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | RETROPHIN INC | 28,634 | 391,000 | 0.54% | ||
| 52 | TC PIPELINES LP | 8,068 | 389,000 | 0.54% | ||
| 53 | REGENERON PHARMACEUTICALS | 1,057 | 381,000 | 0.52% | ||
| 54 | INCYTE CORP | 5,113 | 371,000 | 0.51% | ||
| 55 | INOVIO PHARMACEUTICALS INC | 40,487 | 353,000 | 0.49% | ||
| 56 | HALOZYME THERAPEUTICS INC | 36,695 | 348,000 | 0.48% | ||
| 57 | MOMENTA PHARMACEUTICALS INC | 37,282 | 344,000 | 0.47% | ||
| 58 | NGL ENERGY PARTNERS LP | 40,261 | 303,000 | 0.42% | ||
| 59 | ADVAXIS INC COM NEW | 31,328 | 283,000 | 0.39% | ||
| 60 | Anacor Pharmaceuticals Inc | 5,147 | 275,000 | 0.38% | ||
| 61 | AGENUS INC | 64,543 | 268,000 | 0.37% | ||
| 62 | SANOFI SPOND FUNSPONSORED ADR | 31,577 | 264,000 | 0.36% | ||
| 63 | Spectra Energy Corp Com | 8,481 | 260,000 | 0.36% | ||
| 64 | FIVE PRIME THERAPEUTICS INC | 6,321 | 257,000 | 0.35% | ||
| 65 | XENCOR INC COM | 18,040 | 242,000 | 0.33% | ||
| 66 | LOXO ONCOLOGY INC COM | 8,712 | 238,000 | 0.33% | ||
| 67 | AMICUS THERAPEUTICS INC COM | 27,420 | 232,000 | 0.32% | ||
| 68 | LEXICON PHARMACEUTICALS INC | 19,267 | 230,000 | 0.32% | ||
| 69 | ADAPTIMMUNE THERAPEUTICS PLC | 28,182 | 229,000 | 0.32% | ||
| 70 | PARATEK PHARMACEUTICALS INC | 14,884 | 226,000 | 0.31% | ||
| 71 | ARBUTUS BIOPHARMA CORP | 54,471 | 225,000 | 0.31% | ||
| 72 | Atara Biotherapeutics Inc | 11,431 | 218,000 | 0.30% | ||
| 73 | IMMUNOMEDICS INCORPORATED | 87,062 | 218,000 | 0.30% | ||
| 74 | TESARO INCORPORATED | 4,904 | 216,000 | 0.30% | ||
| 75 | Arrowhead Pharma Inc | 44,714 | 216,000 | 0.30% | ||
| 76 | ZIOPHARM ONCOLOGY INC | 29,020 | 215,000 | 0.30% | ||
| 77 | REGULUS THERAPEUTICS INC COM | 30,524 | 212,000 | 0.29% | ||
| 78 | ACADIA PHARMACEUTICALS INC COM | 7,357 | 206,000 | 0.28% | ||
| 79 | JUNO THERAPEUTICS INC COM | 5,353 | 204,000 | 0.28% | ||
| 80 | TG THERAPEUTICS INC COM | 23,986 | 204,000 | 0.28% | ||
| 81 | LA JOLLA PHARMACEUTICAL CO | 9,645 | 202,000 | 0.28% | ||
| 82 | AGIOS PHARMACEUTICALS INC | 4,954 | 201,000 | 0.28% | ||
| 83 | EPIZYME INC COM | 16,400 | 199,000 | 0.27% | ||
| 84 | TREVENA INC | 23,988 | 198,000 | 0.27% | ||
| 85 | ACHILLION PHARMACEUTICALS IN | 25,711 | 198,000 | 0.27% | ||
| 86 | INTERCEPT PHARMACEUTICALS INCORPORATED | 1,535 | 197,000 | 0.27% | ||
| 87 | ARRAY BIOPHARMA INC | 66,376 | 196,000 | 0.27% | ||
| 88 | CROSSTEX ENERGY INC | 17,251 | 194,000 | 0.27% | ||
| 89 | SORRENTO THERAPEUTICS INC COM NEW | 36,130 | 194,000 | 0.27% | ||
| 90 | UNITED STATES OIL FUND LP | 20,000 | 194,000 | 0.27% | ||
| 91 | AKEBIA THERAPEUTICS INC | 21,430 | 193,000 | 0.27% | ||
| 92 | BLUEPRINT MEDICINES CORP COM | 10,484 | 189,000 | 0.26% | ||
| 93 | DYNAVAX TECHNOLOGIES CORP | 9,768 | 188,000 | 0.26% | ||
| 94 | NEUROCRINE BIOSCIE COM USD0.001 | 4,760 | 188,000 | 0.26% | ||
| 95 | INSMED INC | 14,788 | 187,000 | 0.26% | ||
| 96 | Esperion Therapeutics Inc | 11,011 | 186,000 | 0.26% | ||
| 97 | AIMMUNE THERAPEUTICS INC COM | 13,666 | 185,000 | 0.25% | ||
| 98 | KITE PHARMA INCORPORATED | 3,940 | 181,000 | 0.25% | ||
| 99 | BLUEBIRD BIO INC COM | 4,252 | 181,000 | 0.25% | ||
| 100 | INFINITY PHARMACEUTICALS INC | 34,021 | 179,000 | 0.25% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017478, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
